This study is accepting new patients by invitation only
Extension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry Disease
Summary
- Eligibility
- for people ages 18-60 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Protalix
- ID
- NCT03566017
- Phase
- Phase 3 Fabry Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 110 study participants
- Last Updated